Development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer.

Health Expect

Sisters of Charity of Ottawa Health Service, Ottawa, Canada; Ottawa Hospital-Civic Campus, Ottawa, Canada; University of Ottawa, Ottawa, Canada; Clinical Epidemiology Unit, Loeb Health Research Institute at the Ottawa Hospital-Civic Campus, Ottawa, Canada; Ottawa Regional Cancer Centre, Ottawa, Canada; Ottawa Regional Women's Breast Health Centre, Ottawa Hospital-Civic Campus, Ottawa, Canada.

Published: June 2000

Although guidelines for treating stage IV non-small cell lung cancer suggest that the patient's values should be considered in decision-making, there are no practical tools available to assist them with their decision-making. OBJECTIVE: To develop and evaluate a decision aid that incorporates patient values. DESIGN AND SAMPLE: (1) Before/after evaluation with patients referred to a regional cancer centre. (2) Mailed survey of thoracic surgeons and respirologists in Ontario. INTERVENTION: An audio-tape guided individuals to review a booklet describing stage IV non-small cell lung cancer, its impact and possible coping strategies, treatment options, benefits and risks, and examples of the decision-making of others. Patients then used a worksheet to consider and communicate personal issues involved in the choice, including: personal values using a 'weigh-scale'; questions; preferred role in decision-making; and predisposition. MEASURES: (1) Patient questionnaires eliciting knowledge, the decision, decisional conflict and acceptability of the decision aid. (2) Physician questionnaires eliciting attitudes toward the decision aid. RESULTS: (1) Twenty of 30 patients used the aid in decision-making. Users thought that the aid was acceptable and significantly improved their knowledge about options and outcomes (P < 0.001), and reduced their decisional conflict (P < 0.001). (2) The majority of the 29 physicians who reviewed the decision aid found it acceptable, were comfortable providing it to patients and said that they were likely to use it. CONCLUSION: The decision aid is a useful and acceptable adjunct to personal counselling.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080958PMC
http://dx.doi.org/10.1046/j.1369-6513.2000.00067.xDOI Listing

Publication Analysis

Top Keywords

decision aid
24
stage non-small
12
non-small cell
12
cell lung
12
lung cancer
12
aid acceptable
12
aid
8
questionnaires eliciting
8
decisional conflict
8
decision
7

Similar Publications

Background: Studies show that tube feeding does not improve clinical outcomes, and professional guidelines recommend against its use for individuals with advanced dementia. Yet, our preliminary work demonstrates a preference for tube feeding among Chinese-American dementia caregivers. We propose linguistic and cultural adaptation of "Making Choices: Feeding Options for Patients with Dementia (MCFODA) to create the Chinese version of this efficacious decision aid intervention.

View Article and Find Full Text PDF

Background: People with dementia have complex palliative care needs including psycho-social, physical and spiritual; however, they are often unmet. It is important to empower people with dementia, family caregivers and professionals to work together to better assess and monitor ongoing needs. This study aimed to co-design and test the feasibility of an integrated model of palliative dementia care to support holistic assessment and decision making for care in the community and care homes (assisted living facilities).

View Article and Find Full Text PDF

Dementia Care Practice.

Alzheimers Dement

December 2024

Audition Technology, Pittsburgh, PA, USA.

The recent ACHIEVE study (https://www.achievestudy.org/) demonstrated the substantial benefit of hearing aid use in those with mild-moderate hearing loss and at increased risk for cognitive decline.

View Article and Find Full Text PDF

Multiparametric MRI for Assessment of the Biological Invasiveness and Prognosis of Pancreatic Ductal Adenocarcinoma in the Era of Artificial Intelligence.

J Magn Reson Imaging

January 2025

Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China.

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest malignant tumor, with a grim 5-year overall survival rate of about 12%. As its incidence and mortality rates rise, it is likely to become the second-leading cause of cancer-related death. The radiological assessment determined the stage and management of PDAC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!